Open AccessIn Silico Prediction of T and B Cell Epitopes of SAG1-Related Sequence 3 (SRS3) Gene for Developing Toxoplasma gondii Vaccine
Author(s) -
Abolfazl Mirzadeh,
Geita Saadatnia,
Majid Golkar,
Jalal Babaie,
Sasan Amiri,
Asiyeh Yoosefy
Publication year - 2020
Publication title -
archives of clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.22
H-Index - 14
ISSN - 2345-2641
DOI - 10.5812/archcid.69241
Subject(s) - antigenicity , in silico , epitope , toxoplasma gondii , dna vaccination , biology , antigen , gene , virology , toxoplasmosis , reverse vaccinology , computational biology , antibody , genetics , recombinant dna
: Toxoplasmosis is a worldwide infection that can lead to serious problems in immune-compromised individuals and fetuses. A DNA vaccine strategy would be an ideal tool against Toxoplasma gondii. One of the necessary measures to provide an effective vaccine is the selection of proteins with high antigenicity. The SAG1-related sequence 3 (SRS3) protein is a major surface antigen in T. gondii that can be used as a vaccine candidate. In the present study, bioinformatics and computational methods were utilized to predict protein characteristics, as well as secondary and tertiary structures. The in silico approach is highly suited to analyze, design, and evaluate DNA vaccine strategies. Hence, in silico prediction was used to identify B and T cell epitopes and compare the antigenicity of SRS3 and other candidate genes of Toxoplasma previously applied in the production of vaccines. The results of the analysis theoretically showed that SRS3 has multiple epitopes with high antigenicity, proposing that SRS3 is a promising immunogenic candidate for the development of DNA vaccines against toxoplasmosis.